Hims & Hers Health, Inc.
About Hims & Hers Health, Inc.
Hims, Inc. was founded in November 2017 by Andrew Dudum, Jack Abraham, and Hilary Coles as part of Atomic Labs, a San Francisco venture studio. It initially offered generic prescription treatments for erectile dysfunction and hair loss alongside skincare products, marketed to millennial men through a direct-to-consumer brand. In 2018, Hims launched Hers, a brand targeting women's health needs including birth control, skincare, and hair regrowth treatments. Hims & Hers Health, Inc. completed a business combination with Oaktree Acquisition Corp. and began trading on the NYSE.
- 🔗 Hims & Hers Health - Wikipedia
- 🔗 Hims & Hers Health - Wikipedia
- 🔗 Hims & Hers Health, Inc. Closes Business Combination and Will Begin Trading on the New York Stock Exchange
- 🔗 Hims & Hers closes its SPAC merger, lists on NYSE
- 🔗 Hims Inc. - Hims & Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp.
Investors
Key highlights
- Completed SPAC merger with Oaktree Acquisition Corp. delivering up to $280 million in cash.
- Values combined company at approximately $1.6 billion enterprise value.
- Management and existing equity holders rolled nearly 100% of equity into the public company.
- Plans to use proceeds to invest in growth and new product categories as the digital front door to healthcare.
Ask StreetZero about Hims & Hers Health, Inc.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NYSE) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account